Company News

Valeant Buys PreCision Dermatology

$475 million deal includes derm-dispensed PrecisionMD skin care products.

Author Image

By: Christine Esposito

Editor-in-Chief

Valeant Pharmaceuticals has entered into a definitive agreement to acquire PreCision Dermatology, Inc. for $475 million in cash, plus an additional $25 million payable upon the achievement of a sales-based milestone.  PreCision develops and markets high quality dermatology products such as Locoid, Hylatopic, Clindagel, and BenzEFoam.  “PreCision Dermatology has a wide range of medical dermatology products, treating a number of topical disease states such as acne and atopic dermatitis, and...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters